Top Sell
Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▲ | Target price | Potential |
---|---|---|---|---|---|---|---|
Gritstone Oncology Inc | 2 | 2 | 0 | 0 | €0.89 | €6.53 | 632.997% |
Atara Biotherapeutics Inc. | 2 | 3 | 0 | 0 | €0.59 | €3.00 | 409.165% |
Nymox Pharmaceutical Corp. | 0 | 2 | 0 | 0 | €0.23 | - | - |
Karyopharm Therapeutics Inc. | 7 | 2 | 0 | 0 | €1.08 | €3.65 | 238.701% |
Organovo Holdings Inc. | 0 | 6 | 0 | 1 | €0.89 | €3.00 | 236.323% |
Minerva Neurosciences Inc. | 1 | 5 | 0 | 0 | €2.26 | €7.00 | 209.735% |
Formycon AG | 3 | 1 | 0 | 0 | €46.10 | €100.00 | 116.920% |
Corvus Pharmaceuticals Inc | 4 | 1 | 0 | 1 | €1.56 | €5.10 | 226.229% |
Neptune Wellness Solutions Inc | 0 | 13 | 0 | 0 | €0.14 | - | - |
Coherus Bioscien. | 2 | 2 | 0 | 0 | €2.06 | €3.00 | 45.773% |
Trevena Inc. | 1 | 14 | 0 | 3 | €0.35 | €8.37 | 2263.390% |
Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 2 | 0 | €36.20 | €50.00 | 38.122% |
Biofrontera AG | 0 | 2 | 0 | 0 | €0.33 | €0.000 | -100.000% |
Ocuphire Pharma Inc. | 5 | 1 | 0 | 0 | €1.87 | €18.30 | 877.350% |
Synthetic Biologics Inc. | 0 | 1 | 0 | 1 | €0.40 | - | - |
Medigene AG | 0 | 2 | 0 | 0 | €1.48 | €1.00 | -32.203% |
Sangamo Therapeutics Inc. | 11 | 13 | 0 | 1 | €0.49 | €2.79 | 469.370% |
Protalix Biotherapeutics Inc. | 1 | 2 | 0 | 2 | €1.04 | €2.00 | 93.143% |
Palisade Bio Inc. | 3 | 1 | 2 | 0 | €0.34 | €21.06 | 6072.333% |
Tonix Pharmaceuticals Holding Corp. | 2 | 16 | 0 | 2 | €2.82 | €5.03 | 78.387% |
Cytomx Therapeutics Inc | 2 | 2 | 2 | 2 | €4.07 | €50.00 | 1127.898% |
Anavex Life Sciences Corp | 0 | 2 | 0 | 0 | €3.56 | - | - |
Novavax Inc. | 4 | 2 | 1 | 0 | €4.42 | €12.00 | 171.708% |
Agenus Inc. | 2 | 2 | 0 | 0 | €0.41 | €7.30 | 1664.911% |
Aspira Womens Health Inc. | 0 | 1 | 0 | 0 | €2.94 | - | - |